| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/24/2008 | WO2006101841A3 Seneca valley virus based compositions and methods for treating disease |
| 01/24/2008 | WO2005121371A3 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 01/24/2008 | WO2004081188A3 Non-toxic membrane-translocating peptides |
| 01/24/2008 | WO2004069206A3 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080020993 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 01/24/2008 | US20080020990 Oligo Double-Stranded Rna Inhibiting the Expression of Bcl-2 and Pharmaceutical Composition Containing the Same |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020463 Entrapped stem cells and uses thereof |
| 01/24/2008 | US20080020441 Passing a sample of minicells over a series of cross-flow filters, then through a dead-end filter; separating sample from contaminants to obtain a purified minicell preparation |
| 01/24/2008 | US20080020406 Antibodies to a human Kchannel and therapeutic applications thereof |
| 01/24/2008 | US20080020041 Enteric Coated Compositions that Release Active Ingredient(s) in Gastric Fluid and Intestinal Fluid |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019971 36P6D5: secreted tumor antigen |
| 01/24/2008 | US20080019953 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 01/24/2008 | US20080019952 Novel Method for the Preparation of Embryoid Bodies (Ebs) and Uses Thereof |
| 01/24/2008 | US20080019946 Integration-type low-dose radiation-inducible vector |
| 01/24/2008 | US20080019945 Attenuation of Cytomegalovirus Virulence |
| 01/24/2008 | CA2692886A1 Phosphorylation of cell membrane bound syndecan-4 triggers its nuclear translocation |
| 01/24/2008 | CA2659032A1 Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 01/24/2008 | CA2658183A1 Rna interference mediated inhibition of proprotein convertase subtilisin kexin 9 (pcsk9) gene expression using short interfering nucleic acid (sina) |
| 01/24/2008 | CA2657767A1 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 01/23/2008 | EP1881327A2 Diagnosis and treatment of malignant neoplasms |
| 01/23/2008 | EP1881075A1 Retroviral vectors having a reduced recombination rate |
| 01/23/2008 | EP1880008A2 Expression of mitochondrial protein by an enhanced allotopic approach |
| 01/23/2008 | EP1879905A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 01/23/2008 | EP1879650A1 Rate control during af using cellular intervention to modulate av node |
| 01/23/2008 | EP1879624A1 Gene therapy for neurometabolic disorders |
| 01/23/2008 | EP1879623A2 Gene therapy for spinal cord disorders |
| 01/23/2008 | EP1879622A2 Permeable capsules |
| 01/23/2008 | EP1879610A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases |
| 01/23/2008 | EP1786471A4 Treating cardiovascular tissue |
| 01/23/2008 | EP1601772B1 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
| 01/23/2008 | EP1578452B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1240332B1 Streptococcus pyogenes virulence genes and proteins and their use |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1175444B1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/23/2008 | EP1141315B1 Modified hiv env polypeptides |
| 01/23/2008 | EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP0870048B1 Host adaptation of retroviral vectors |
| 01/23/2008 | CN101111307A Process for producing coated fine particle |
| 01/23/2008 | CN101111269A Composition for inhibiting expression of target gene |
| 01/23/2008 | CN101109013A Micromolecule nucleotide DNA adaptorprotein against tubercle bacillus infection and method of preparing the same |
| 01/23/2008 | CN101109011A Novel modified corin molecules having substitute activation sequences and uses thereof |
| 01/23/2008 | CN101108882A Fusion protein of HIV regulatory/accessory proteins |
| 01/23/2008 | CN101108253A Biological separation dose treating femoral head ischemic necrosis |
| 01/23/2008 | CN101108245A Formulated product used for human tumour combined treatment and use thereof |
| 01/23/2008 | CN100363492C Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides |
| 01/23/2008 | CN100363392C Preparation for transgenic carrier of temperature-sensitive poly isopropyl acrylamide and poly arginine conjugate |
| 01/23/2008 | CN100363057C Use of melanoma differentiation associated gene (mda-7) for reversing cancerous phenotype |
| 01/22/2008 | US7321030 Tumor-specific promotor and use thereof |
| 01/22/2008 | US7321028 Comprises leucine rich repeat domains; kits; drug screening; for treating apoptosis |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320963 Methods and compositions for delivery of pharmaceutical agents |
| 01/22/2008 | US7320890 Soluble steroidal peptides for nucleic acid delivery |
| 01/22/2008 | US7320863 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/22/2008 | US7320859 Using nucleoprotein filament complexes to transfer nucleotide sequences into cells; nonviral gene therapy |
| 01/22/2008 | US7320787 Genetic engineering; desroying infections; antitumor, anticancer agents |
| 01/22/2008 | US7320679 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
| 01/22/2008 | CA2408251C Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 01/17/2008 | WO2008008814A2 Tissue transplantation compositions and methods |
| 01/17/2008 | WO2008008719A2 Compositions and methods for inhibiting expression of the myc gene |
| 01/17/2008 | WO2008008476A2 Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups |
| 01/17/2008 | WO2008008365A2 Biocompatible hydrogels |
| 01/17/2008 | WO2008008276A2 Tetracycline repressor regulated oncolytic viruses |
| 01/17/2008 | WO2008007581A1 Non-replicating paramyxoviridae virus vector |
| 01/17/2008 | WO2008006458A2 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 01/17/2008 | WO2007062048A3 Role of proteoglycans in drug dependence |
| 01/17/2008 | WO2007053802A3 Drug and gene delivery by polymer nanonozzle and nanotip cell patch |
| 01/17/2008 | WO2007047482B1 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics |
| 01/17/2008 | WO2007016239A3 Herpes simplex virus mutant and uses therefore |
| 01/17/2008 | WO2005037999A3 Treatment of cancer using antibodies to lrrc15 |
| 01/17/2008 | US20080015337 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 01/17/2008 | US20080015163 Mice lacking alpha 1g showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1g t-type calcium channels |
| 01/17/2008 | US20080015162 Compounds and methods for modulating gene expression |
| 01/17/2008 | US20080015160 Using concentration of cancer-associated gene products as diagnostic tool in detection of pancreatic cell proliferative disorders |
| 01/17/2008 | US20080015153 Pharmaceutical compositions containing the long pentraxin PTX3 |
| 01/17/2008 | US20080014624 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs |
| 01/17/2008 | US20080014620 Fermentation of pentose sugars |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014185 Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth |
| 01/17/2008 | US20080014183 Anticancer Agent Containing Dendritic Cell Having Rna Virus Transferred Thereinto |
| 01/17/2008 | US20080014179 Tissue transplantation compositions and methods |
| 01/17/2008 | US20080014175 Methods and Compositions for Viral Enhancement of Cell Killing |
| 01/17/2008 | DE19907485B4 Virus-Vakzine Virus vaccine |
| 01/17/2008 | DE102006032424A1 Behandlung von T-Zell-Malignomen Treatment of T-cell malignancies |
| 01/17/2008 | CA2658266A1 Non-replicating paramyxoviridae virus vector |
| 01/17/2008 | CA2654149A1 Biocompatible hydrogels |
| 01/16/2008 | EP1878804A1 Perkinson disease-related gene grk5 and use thereof |
| 01/16/2008 | EP1878744A1 Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 01/16/2008 | EP1877436A2 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues |
| 01/16/2008 | EP1877427A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 01/16/2008 | EP1877103A2 Dendritic polymers with enhanced amplification and interior functionality |
| 01/16/2008 | EP1599231A4 Treatment of pain through expression of opioid receptors |
| 01/16/2008 | EP1279039B1 Diagnostic assay involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |